Evidence map›Paper›PMID 39289743›Full record

ArticleBMC research notes2024

Evaluation of chicken embryo extract and egg yolk extract as alternatives to basic cell culture medium supplement.

Fregenet Mulugeta, Teferi Degefa, Demise Mulugeta, Anberber Alemu, Jitu Beka, Henok Ferede, Dereje Nigussie Woldemichael, Fanos Tadesse Woldemariyam

Abstract read
In one paragraph

Article in BMC research notes, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Fregenet MulugetaCollege of Veterinary Medicine and Agriculture, Addis Ababa University, P.O. Box:34, Bishoftu, Ethiopia.
Teferi DegefaNational Veterinary Institute, P.O. Box: 19, Bishoftu, Ethiopia.
Demise MulugetaVaccine, Diagnostics and Medical Device Research and Development Directorate, Armauer Hansen Research Institute Jimma Road, ALERT Campus, P.O. Box: 1005, Addis Ababa, Ethiopia.
Anberber AlemuVaccine, Diagnostics and Medical Device Research and Development Directorate, Armauer Hansen Research Institute Jimma Road, ALERT Campus, P.O. Box: 1005, Addis Ababa, Ethiopia.
Jitu BekaInstitute of health, School of Public Health, Bule Hora Univesity, P.O. Box: 44, Bule Hora, Ethiopia.
Henok FeredeVaccine, Diagnostics and Medical Device Research and Development Directorate, Armauer Hansen Research Institute Jimma Road, ALERT Campus, P.O. Box: 1005, Addis Ababa, Ethiopia.
Dereje Nigussie WoldemichaelVaccine, Diagnostics and Medical Device Research and Development Directorate, Armauer Hansen Research Institute Jimma Road, ALERT Campus, P.O. Box: 1005, Addis Ababa, Ethiopia.
Fanos Tadesse WoldemariyamVaccine, Diagnostics and Medical Device Research and Development Directorate, Armauer Hansen Research Institute Jimma Road, ALERT Campus, P.O. Box: 1005, Addis Ababa, Ethiopia. fanos.tadesse@aau.edu.et.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFetal calf serum (FCS), an existing cell culture supplement, is effective but has several drawbacks, including being expensive, requiring a lengthy process of production, and requiring a hard currency. With this in mind, we planned to evaluate chick embryo extract and egg yolk extracts in cell culture as alternatives to fetal calf serum (FCS).

methodsSpecific pathogen-free eggs were purchased from the National Veterinary Institute, Bishoftu, Ethiopia, and incubated in a humidified incubator at 37 °C for 11 days. Egg yolk extract (EYE) and chick embryo extract (CEE) were collected after the egg was opened with caution not to destroy the yolk sack or the chick embryo itself. Chick fibroblasts and Vero cells were cultured in minimum essential medium (MEM) supplemented with egg yolk extract or chick embryo extract at ratios of 0:10, 1:9, 2.5:7.5, and 5:5% fetal calf serum.

resultsFibroblast cell attachment was better in media supplemented with 5% CEE and 5% FCS. The confluency was also greater than 50% at this concentration. Vero cells cultured with 5% CEE and 5% FCS also exhibited very good cell attachment and a confluency of up to 70%. Viability and confluency were also observed at 5%:5% ratios of 50 and 70%, respectively.

conclusionThis investigation evaluated these two extracts as cell culture supplements and revealed promising results as alternatives to fetal calf serum. The limitation of this study is that it only used two cell types and additional cell lines, and different ratios should be tested. With the above findings, further research using different cell lines, ratios and conditions is warranted.

Indexed as

Cell Culture TechniquesCulture MediaEgg YolkFibroblastsAnimalsCell SurvivalChick EmbryoChlorocebus aethiopsTissue ExtractsVero CellsCulture MediaTissue ExtractsCell attachmentCell cultureCell viabilityChicken embryo extractConfluencyEgg yolk extractFetal calf serum

Identifiers

PMID39289743
PMCPMC11409745

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.